Renaissance Technologies - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 33 filers reported holding NRX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$89
-3.3%
188,780
-5.8%
0.00%
Q4 2023$92
+114.0%
200,480
+22.4%
0.00%
Q3 2023$43
+168.8%
163,780
+388.9%
0.00%
Q2 2023$16
-5.9%
33,500
+32.4%
0.00%
Q1 2023$17
-15.0%
25,300
+43.8%
0.00%
Q4 2022$20
-99.8%
17,600
+21.8%
0.00%
Q3 2022$11,000
-45.0%
14,445
-56.1%
0.00%
Q2 2022$20,000
-94.1%
32,900
-76.3%
0.00%
Q1 2022$341,000139,0030.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 642,632$295,6110.07%
One Wealth Management Investment & Advisory Services, LLC 140,402$64,5850.03%
Texas Capital Bank Wealth Management Services Inc 63,290$29,1130.00%
HighPoint Advisor Group LLC 43,501$23,0000.00%
HBK Sorce Advisory LLC 29,230$13,4460.00%
United Asset Strategies, Inc. 18,300$8,4180.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 122,700$56,4420.00%
NORTHERN TRUST CORP 74,996$34,4980.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 46,837$21,5450.00%
View complete list of NRX PHARMACEUTICALS INC shareholders